These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9765353

  • 1. Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species.
    Tsao LI, Ladenheim B, Andrews AM, Chiueh CC, Cadet JL, Su TP.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):322-31. PubMed ID: 9765353
    [Abstract] [Full Text] [Related]

  • 2. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
    Hayashi T, Hirata H, Asanuma M, Ladenheim B, Tsao LI, Cadet JL, Su TP.
    Synapse; 2001 Mar 15; 39(4):305-12. PubMed ID: 11169780
    [Abstract] [Full Text] [Related]

  • 3. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y, Gandia C, Huang PL, Ali SF.
    J Pharmacol Exp Ther; 1998 Mar 15; 284(3):1040-7. PubMed ID: 9495865
    [Abstract] [Full Text] [Related]

  • 4. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR, Haughey HM, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2000 Dec 15; 295(3):1077-85. PubMed ID: 11082443
    [Abstract] [Full Text] [Related]

  • 5. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
    Wu PH, Shen YC, Wang YH, Chi CW, Yen JC.
    Toxicology; 2006 Sep 21; 226(2-3):238-45. PubMed ID: 16887252
    [Abstract] [Full Text] [Related]

  • 6. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
    Itzhak Y, Martin JL, Ali SF.
    Synapse; 1999 Dec 15; 34(4):305-12. PubMed ID: 10529724
    [Abstract] [Full Text] [Related]

  • 7. Reversal by [D-Ala2,D-Leu5]enkephalin of the dopamine transporter loss caused by methamphetamine.
    Tsao LI, Cadet JL, Su TP.
    Eur J Pharmacol; 1999 May 21; 372(3):R5-7. PubMed ID: 10395030
    [Abstract] [Full Text] [Related]

  • 8. Rapid and reversible effects of methamphetamine on dopamine transporters.
    Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1997 Aug 21; 282(2):834-8. PubMed ID: 9262348
    [Abstract] [Full Text] [Related]

  • 9. Tolerance and cross-tolerance to the antisecretory effects of enkephalins on the guinea-pig ileal mucosa.
    Vinayek R, Brown DR, Miller RJ.
    J Pharmacol Exp Ther; 1985 Mar 21; 232(3):781-5. PubMed ID: 2983070
    [Abstract] [Full Text] [Related]

  • 10. The effects of methamphetamine on the production of free radicals and oxidative stress.
    Yamamoto BK, Zhu W.
    J Pharmacol Exp Ther; 1998 Oct 21; 287(1):107-14. PubMed ID: 9765328
    [Abstract] [Full Text] [Related]

  • 11. Free radical production induced by methamphetamine in rat striatal synaptosomes.
    Pubill D, Chipana C, Camins A, Pallàs M, Camarasa J, Escubedo E.
    Toxicol Appl Pharmacol; 2005 Apr 01; 204(1):57-68. PubMed ID: 15781294
    [Abstract] [Full Text] [Related]

  • 12. Picomolar concentrations of hibernation induction delta opioid peptide [D-Ala2,D-Leu5]enkephalin increase the nerve growth factor in NG-108 cells.
    Tsai SY, Hayashi T, Su TP.
    Synapse; 2005 Sep 01; 57(3):179-81. PubMed ID: 15945062
    [Abstract] [Full Text] [Related]

  • 13. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
    Kaewsuk S, Sae-ung K, Phansuwan-Pujito P, Govitrapong P.
    Neurochem Int; 2009 Nov 01; 55(6):397-405. PubMed ID: 19409439
    [Abstract] [Full Text] [Related]

  • 14. Delta opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia.
    Wang S, Duan Y, Su D, Li W, Tan J, Yang D, Wang W, Zhao Z, Wang X.
    Eur J Pharmacol; 2011 May 11; 658(2-3):140-4. PubMed ID: 21349267
    [Abstract] [Full Text] [Related]

  • 15. [Protective effects of a delta-opioid-receptor agonist and an oxygen radical scavenger on postischemic hearts].
    Schipke JD, Nickel F, Gams E, Sunderdiek U.
    Herz; 2004 May 11; 29(3):331-40. PubMed ID: 15167961
    [Abstract] [Full Text] [Related]

  • 16. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
    Iwashita A, Mihara K, Yamazaki S, Matsuura S, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.
    J Pharmacol Exp Ther; 2004 Sep 11; 310(3):1114-24. PubMed ID: 15113847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Up-regulation of delta opioid receptors in neuroblastoma hybrid cells: evidence for differences in the mechanisms of action of sodium butyrate and naltrexone.
    Belcheva MM, Barg J, McHale RJ, Gao XM, Chuang DM, Coscia CJ.
    J Pharmacol Exp Ther; 1991 Oct 11; 259(1):302-9. PubMed ID: 1656025
    [Abstract] [Full Text] [Related]

  • 19. Delta opioid receptors stimulation with [D-Ala2, D-Leu5] enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia.
    Iwata M, Inoue S, Kawaguchi M, Kurita N, Horiuchi T, Nakamura M, Konishi N, Furuya H.
    Neurosci Lett; 2007 Mar 13; 414(3):242-6. PubMed ID: 17207574
    [Abstract] [Full Text] [Related]

  • 20. Detection of methamphetamine neurotoxicity in forensic autopsy cases.
    Kitamura O.
    Leg Med (Tokyo); 2009 Apr 13; 11 Suppl 1():S63-5. PubMed ID: 19269222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.